124 related articles for article (PubMed ID: 30112120)
1. Correction: Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
Oncotarget; 2018 Jul; 9(56):30937. PubMed ID: 30112120
[TBL] [Abstract][Full Text] [Related]
2. Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis.
Marciel MP; Khadka VS; Deng Y; Kilicaslan P; Pham A; Bertino P; Lee K; Chen S; Glibetic N; Hoffmann FW; Matter ML; Hoffmann PR
Oncotarget; 2018 Mar; 9(17):13407-13422. PubMed ID: 29568366
[TBL] [Abstract][Full Text] [Related]
3. Correction: Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.
Kakar SS; Parte S; Carter K; Joshua IG; Worth C; Rameshwar P; Ratajczak MZ
Oncotarget; 2020 Aug; 11(32):3103-3104. PubMed ID: 32850014
[TBL] [Abstract][Full Text] [Related]
4. Correction: Se
Zhang HN; Feng WL; An CN; Li WG
Oncotarget; 2018 Nov; 9(92):36542. PubMed ID: 30559936
[TBL] [Abstract][Full Text] [Related]
5. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
[TBL] [Abstract][Full Text] [Related]
6. Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.
Hanson K; Robinson SD; Al-Yousuf K; Hendry AE; Sexton DW; Sherwood V; Wheeler GN
Oncotarget; 2018 Nov; 9(93):36645. PubMed ID: 30564304
[TBL] [Abstract][Full Text] [Related]
7. Correction: Inhibition of fibroblast secreted QSOX1 perturbs extracellular matrix in the tumor microenvironment and decreases tumor growth and metastasis in murine cancer models.
Feldman T; Grossman-Haham I; Elkis Y; Vilela P; Moskovits N; Barshack I; Salame TM; Fass D; Ilani T
Oncotarget; 2020 Oct; 11(40):3687. PubMed ID: 33088428
[TBL] [Abstract][Full Text] [Related]
8. Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget.
Qiu YQ; Yang CW; Lee YZ; Yang RB; Lee CH; Hsu HY; Chang CC; Lee SJ
Oncotarget; 2019 Aug; 10(47):4919. PubMed ID: 31448057
[TBL] [Abstract][Full Text] [Related]
9. Correction: Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.
Kang MH; Jeong GS; Smoot DT; Ashktorab H; Hwang CM; Kim BS; Kim HS; Park YY
Oncotarget; 2018 Dec; 9(98):37268. PubMed ID: 30647858
[TBL] [Abstract][Full Text] [Related]
10. Correction: Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
Oncotarget; 2021 Mar; 12(5):519-520. PubMed ID: 33747364
[TBL] [Abstract][Full Text] [Related]
11. Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.
Bjoern J; Lyngaa R; Andersen R; Hölmich LR; Hadrup SR; Donia M; Svane IM
Oncotarget; 2018 Nov; 9(88):35870. PubMed ID: 30533201
[TBL] [Abstract][Full Text] [Related]
12. Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Tsai CH; Tsai HC; Huang HN; Hung CH; Hsu CJ; Fong YC; Hsu HC; Huang YL; Tang CH
Oncotarget; 2018 Oct; 9(85):35598. PubMed ID: 30473753
[TBL] [Abstract][Full Text] [Related]
13. Correction: A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands.
Qin T; Barron L; Xia L; Huang H; Villarreal MM; Zwaagstra J; Collins C; Yang J; Zwieb C; Kodali R; Hinck CS; Kim SK; Reddick RL; Shu C; O'Connor-McCourt MD; Hinck AP; Sun LZ
Oncotarget; 2017 Aug; 8(34):57905. PubMed ID: 28915722
[TBL] [Abstract][Full Text] [Related]
14. Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression.
Hu MH; Ma CY; Wang XM; Ye CD; Zhang GX; Chen L; Wang JG
Oncotarget; 2021 Aug; 12(18):1859-1860. PubMed ID: 34504658
[TBL] [Abstract][Full Text] [Related]
15. Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
Oncotarget; 2018 Aug; 9(60):31787. PubMed ID: 30167094
[TBL] [Abstract][Full Text] [Related]
16. Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer.
Guan B; Wu K; Zeng J; Xu S; Mu L; Gao Y; Wang K; Ma Z; Tian J; Shi Q; Guo P; Wang X; He D; Du Y
Oncotarget; 2022; 13():507. PubMed ID: 35284038
[TBL] [Abstract][Full Text] [Related]
17. Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity.
Jiang Y; Ma Y; Li R; Sun J
Oncotarget; 2018 Aug; 9(60):31788. PubMed ID: 30167095
[TBL] [Abstract][Full Text] [Related]
18. Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer.
Zhang S; Che D; Yang F; Chi C; Meng H; Shen J; Qi L; Liu F; Lv L; Li Y; Meng Q; Liu J; Shang L; Yu Y
Oncotarget; 2020 Dec; 11(52):4845-4846. PubMed ID: 33447352
[TBL] [Abstract][Full Text] [Related]
19. Correction: MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
Qiu W; Yang Z; Fan Y; Zheng Q
Oncotarget; 2022; 13():614. PubMed ID: 35419172
[TBL] [Abstract][Full Text] [Related]
20. Correction: Recurrent mutations in a
Zeng W; Hu B; Tang L; You YY; Toderici M; Eugenia de la Morena-Barrio M; Corral J; Hu Y
Oncotarget; 2018 Feb; 9(13):11428. PubMed ID: 29542734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
